Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Invested Capital (2020 - 2025)

Biofrontera has reported Invested Capital over the past 6 years, most recently at $10.5 million for Q4 2025.

  • Quarterly results put Invested Capital at $10.5 million for Q4 2025, up 136.41% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (up 136.41% YoY), and the annual figure for FY2025 was $10.5 million, up 136.41%.
  • Invested Capital for Q4 2025 was $10.5 million at Biofrontera, up from -$2.6 million in the prior quarter.
  • Over the last five years, Invested Capital for BFRIW hit a ceiling of $30.8 million in Q4 2022 and a floor of -$17.4 million in Q3 2021.
  • Median Invested Capital over the past 5 years was $7.7 million (2023), compared with a mean of $8.0 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 1359.72% in 2022 and later crashed 146.67% in 2025.
  • Biofrontera's Invested Capital stood at $14.6 million in 2021, then surged by 111.39% to $30.8 million in 2022, then tumbled by 71.78% to $8.7 million in 2023, then crashed by 49.03% to $4.4 million in 2024, then surged by 136.41% to $10.5 million in 2025.
  • The last three reported values for Invested Capital were $10.5 million (Q4 2025), -$2.6 million (Q3 2025), and -$4.7 million (Q2 2025) per Business Quant data.